Recurrent basal cell carcinoma in patient treated by cryotherapy

Basal cell carcinoma (bcc) of the skin is the most common malignancy in the human population. one of the most negative features of this disease is frequent tumor recurrence. unfortunately, all of the traditional diagnostic criteria have failed to definitively predict which patients should be considered at high risk of recurrence. we present an 88-year-old man with recurrent bcc (superficiale multicentricum) occurring three years after successful treatment of bcc (morpheiforme) with cryotherapy. careful monitoring must be undertaken for at least 3 years; however, the most appropriate course is a lifetime of regular follow-up.